Several studies have confirmed elevated BMP2 receptor levels induced by IL-6 signaling can activate SMAD1/5/8 and dampen the SMAD 2/3 pathway in idiopathic pulmonary fibrosis [20]. This evidence concerns the gene IL6 and pulmonary fibrosis.